World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
8114
World Ranking
4168
National Ranking
1902

Martin J. Cannon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Martin J. Cannon sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 133 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Martin J. Cannon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Martin J. Cannon sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Martin J. Cannon is affiliated with the University of Arkansas for Medical Sciences in the United States. Their research output spans multiple fields within biomedical sciences, with a focus on medicine, immunology and microbiology, and biochemistry, genetics and molecular biology.

Their subfields of study include immunology, genetics, oncology, epidemiology, and animal science and zoology. The main topics of their work concentrate on virus-based gene therapy research, immunotherapy and immune responses, herpesvirus infections and treatments, animal virus infections studies, cancer research and treatments, cancer immunotherapy and biomarkers, and immune cells in cancer.

Martin J. Cannon has published frequently in venues such as bioRxiv (Cold Spring Harbor Laboratory), Cancer Research, Nature Communications, Journal for ImmunoTherapy of Cancer, and PLoS Pathogens. Their research collaborations include frequent coauthors Alexei G. Basnakian, Steven R. Post, Bolni Marius Nagalo, Camila Simões, and Mulu Z. Tesfay.

Recent papers authored or coauthored by Martin J. Cannon include the following:

  • Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients, 2020, Nature Communications
  • Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade, 2023, Journal for ImmunoTherapy of Cancer
  • Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human monocytes/macrophages, 2022, PLoS Pathogens
  • Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers, 2022, Hepatology
  • Building Up While Shutting Down: An Academic Health System Educational Response to the COVID-19 Pandemic, 2020, MedEdPublish

Best Publications

  • Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.

    M. J. Cannon;P. J. M. Openshaw;B. A. Askonas

  • Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.

    Alessandro D. Santin;Fenghuang Zhan;Eliana Bignotti;Eric R. Siegel

  • Endemic Burkitt's lymphoma: a polymicrobial disease?

    Rosemary A. Rochford;Martin J. Cannon;Ann M. Moormann

  • Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.

    Alessandro D. Santin;Paul L. Hermonat;Antonella Ravaggi;Stefania Bellone

  • Induction of Human Papillomavirus-Specific CD4+ and CD8+ Lymphocytes by E7-Pulsed Autologous Dendritic Cells in Patients with Human Papillomavirus Type 16- and 18-Positive Cervical Cancer

    Alessandro D. Santin;Paul L. Hermonat;Antonella Ravaggi;Antonella Ravaggi;Maurizio Chiriva-Internati

  • Overexpression of HER-2/neu in uterine serous papillary cancer.

    Alessandro D Santin;Stefania Bellone;Murat Gokden;Michela Palmieri

  • Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells.

    M J Cannon;E J Stott;G Taylor;B A Askonas

  • Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice.

    M J Cannon;P Pisa;R I Fox;N R Cooper

  • Human Papillomavirus Type 16 and 18 E7-Pulsed Dendritic Cell Vaccination of Stage IB or IIA Cervical Cancer Patients: a Phase I Escalating-Dose Trial

    Alessandro D. Santin;Stefania Bellone;Michela Palmieri;Alessandro Zanolini

  • Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen.

    R. M. Pemberton;M. J. Cannon;P. J. M. Openshaw;L. A. Ball

  • IL10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer

    Purushottam Lamichhane;Lavakumar Karyampudi;Barath Shreeder;James Krempski

  • Treatment of Chemotherapy-Resistant Human Ovarian Cancer Xenografts in C.B-17/SCID Mice by Intraperitoneal Administration of Clostridium perfringens Enterotoxin

    Alessandro D. Santin;Stefania Cané;Stefania Bellone;Michela Palmieri

  • Cytotoxic T-cell response to respiratory syncytial virus in mice.

    C R Bangham;M J Cannon;D T Karzon;B A Askonas

  • Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.

    Alessandro D. Santin;Stefania Bellone;Eric R. Siegel;Michela Palmieri

  • HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities

    Alessandro D. Santin;Stefania Bellone;Michela Palmieri;Antonella Ravaggi

  • Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix

    Alessandro D Santin;Paul L Hermonat;Antonella Ravaggi;Antonella Ravaggi;Stefania Bellone;Stefania Bellone

  • High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer

    Stefania Bellone;Katherine Watts;Stefania Cane;Michela Palmieri

  • Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy

    A D Santin;F Zhan;Stefania Cané;S Bellone

  • Dendritic Cells and Macrophages Are Productively Infected by Poliovirus

    Rahnuma Wahid;Martin J. Cannon;Marie Chow

  • Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer.

    Alessandro D. Santin;Stefania Bellone;Murat Gokden;Martin J. Cannon

Frequent Co-Authors

Alessandro D. Santin
Alessandro D. Santin Yale University
Sergio Pecorelli
Sergio Pecorelli University of Brescia
Maurizio Chiriva-Internati
Maurizio Chiriva-Internati The University of Texas MD Anderson Cancer Center
W. Martin Kast
W. Martin Kast University of Southern California
Rosemary Rochford
Rosemary Rochford University of Colorado Anschutz Medical Campus
Neil R. Cooper
Neil R. Cooper Scripps Research Institute
Keith L. Knutson
Keith L. Knutson Mayo Clinic
John D. Shaughnessy
John D. Shaughnessy University of Arkansas for Medical Sciences
Peter J. M. Openshaw
Peter J. M. Openshaw Imperial College London
Thomas Kieber-Emmons
Thomas Kieber-Emmons University of Arkansas for Medical Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare roles, particularly in nursing and advanced practice. For those interested in combining immunological knowledge with clinical practice, exploring specialized nursing roles such as psychiatric mental health nurse practitioners can be a smart move. Programs like the cheapest pmhnp programs online provide accessible pathways to enter this growing field.

Understanding the earning potential is equally important. Insights into dnp salary transparency can help you gauge the financial benefits of advanced nursing degrees, such as Doctor of Nursing Practice, which often complement immunology expertise.

For nurses aiming to shift their focus within clinical specialties, transitioning from family nurse practitioner roles to more acute settings is achievable through targeted certifications. Learning about acute care nurse practitioner certification can open doors to critical care environments where immunology plays a vital role.

Accelerated pathways enable motivated students to fast-track their qualifications. The accelerated nurse practitioner program options online offer a streamlined approach for those eager to enter the nursing workforce with advanced skills related to immunology and patient care.

Best Scientists Citing Martin J. Cannon

Trending Scientists

Recently Published Articles